Acceleron Pharma Inc.

NASDAQ: XLRN · Real-Time Price · USD
178.75
0.00 (0.00%)
At close: Apr 24, 2025, 3:47 PM

Acceleron Pharma Balance Sheet Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q3 2021 Q2 2021 Q1 2021
Period Ending Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
336.46M 336.2M 455.51M
Short-Term Investments
254.11M 287.15M 231.74M
Long-Term Investments
61.95M 89.19M 108.19M
Other Long-Term Assets
1.54M 1.71M 1.72M
Receivables
35.66M 29.72M 25.21M
Inventory
n/a n/a n/a
Other Current Assets
70.37M 64.7M 25.16M
Total Current Assets
696.61M 717.77M 737.61M
Property-Plant & Equipment
27.75M 27.38M 28.27M
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
91.24M 118.28M 138.18M
Total Assets
787.85M 836.05M 875.79M
Account Payables
5.09M 9.44M 4.46M
Deferred Revenue
n/a n/a n/a
Short-Term Debt
8.16M 7.55M 7.28M
Other Current Liabilities
44.12M 42.49M 38.07M
Total Current Liabilities
57.37M 59.48M 49.82M
Long-Term Debt
11.95M 13.17M n/a
Other Long-Term Liabilities
373K 373K 15.14M
Total Long-Term Liabilities
12.32M 13.54M 15.14M
Total Liabilities
69.69M 73.02M 64.96M
Total Debt
20.11M 20.72M 22.43M
Common Stock
61K 61K 60K
Retained Earnings
-1.07B -1B -940.91M
Comprehensive Income
-398K -409K -417K
Shareholders Equity
718.15M 763.03M 810.83M
Total Investments
316.06M 376.35M 339.93M